Profile
| Metric | Value |
|---|---|
| Full Name | bluebird bio, Inc. |
| Ticker | NASDAQ: BLUE |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | bluebirdbio.com |
| Employees | 248 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| - | ||
| Price, 1D Change | - | |
| - | ||
| - | ||
| - | ||
| N/A | - | |
| $84M | ||
| Revenue, 1Y Change | +184.12% | |
| -$24.84 | ||
| EPS, 1Y Change | +35.63% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:20 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$24.84 | ||
| EPS Estimate | N/A | -$11.28 |
| EPS Est. Change | N/A | +54.59% |
| $83.81M | ||
| Revenue Estimate | N/A | $154.52M |
| Revenue Est. Change | N/A | +84.38% |
| - | ||
| Price Target | - | $8.00 |
| Price Tgt. Change | - | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$1.71 | -$38.59 | -2,156.73% | |
| -$27.67 | -$24.84 | +10.21% | |
| -$11.28 | N/A | +54.59% | |
| -$5.00 | N/A | +79.87% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $32.32M | $29.50M | -8.73% | |
| $73.23M | $83.81M | +14.44% | |
| $154.52M | N/A | +84.38% | |
| $224.70M | N/A | +168.12% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| - | ||
| - | ||
| +184.12% | ||
| +2,188.56% | ||
| +35.63% | ||
| +89.55% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| - | ||
| N/A | - | |
| SMA 200 vs Price | N/A | - |
| N/A | - | |
| SMA 50 vs Price | N/A | - |
| N/A | - | |
| N/A | - | |
| N/A | - | |
| N/A | - | |
| N/A | - |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| - | ||
| - |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $83.81M | ||
| -$24.84 | ||
| -$5.57M | ||
| -6.65% | ||
| -$267.70M | ||
| -319.42% | ||
| -$240.72M | ||
| -287.23% | ||
| -$156.82M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| -2.27 | ||
| 0.48 | ||
| 0.28 | ||
| -9.66 | ||
| 3 | ||
| - |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| - | ||
| - | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| -$31.53M | ||
| $62.31M | ||
| $460.23M | ||
| $154.67M | ||
| $491.77M | ||
| $321.46M | ||
| $358.24M | ||
| $188.88M | ||
| $34.32M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $351.51M | ||
| $262.13M | ||
| $89.38M | ||
| $167.87M | ||
| $61.24M | ||
| $22.58M | ||
| $70.00K |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$260.02M | ||
| $3.90M | ||
| $87.47M | ||
| $2.60M | ||
| -$262.62M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Barclays | → | |
| Wells Fargo | → | |
| JP Morgan | → | |
| Barclays | → | |
| RBC Capital | → | |
| Barclays | → | |
| B of A Securities | → | |
| Wells Fargo | → | |
| Cantor Fitzgerald | ||
| RBC Capital | → |
Analyst sentiment
Institutional ownership
Screeners with BLUE
FAQ
What is the ticker symbol for bluebird bio, Inc.?
The ticker symbol for bluebird bio, Inc. is NASDAQ:BLUE
Does bluebird bio, Inc. pay dividends?
No, bluebird bio, Inc. does not pay dividends
What sector is bluebird bio, Inc. in?
bluebird bio, Inc. is in the Healthcare sector
What industry is bluebird bio, Inc. in?
bluebird bio, Inc. is in the Biotechnology industry
What country is bluebird bio, Inc. based in?
bluebird bio, Inc. is headquartered in United States
When did bluebird bio, Inc. go public?
bluebird bio, Inc. initial public offering (IPO) was on June 19, 2013
Is bluebird bio, Inc. in the S&P 500?
No, bluebird bio, Inc. is not included in the S&P 500 index
Is bluebird bio, Inc. in the NASDAQ 100?
No, bluebird bio, Inc. is not included in the NASDAQ 100 index
Is bluebird bio, Inc. in the Dow Jones?
No, bluebird bio, Inc. is not included in the Dow Jones index
When was bluebird bio, Inc. last earnings report?
bluebird bio, Inc.'s most recent earnings report was on August 14, 2025
When does bluebird bio, Inc. report earnings?
The date for bluebird bio, Inc.'s next earnings report has not been announced yet
Data Sources & References
- BLUE Official Website www.bluebirdbio.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1293971/000129397125000014/0001293971-25-000014-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1293971/000129397125000009/0001293971-25-000009-index.htm
- BLUE Profile on Yahoo Finance finance.yahoo.com/quote/BLUE
- BLUE Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/blue